PMMA/Silver Nanocomposite Inhibiting Bacterial Growth
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antimicrobial polymeric materials often require high silver content and complex synthesis processes, making them costly and inefficient for widespread application in inhibiting bacterial growth across various surfaces and mediums.
Innovation Solution
A method for producing an antimicrobial poly(methyl methacrylate) (PMMA)/silver nanocomposite by polymerizing methyl methacrylate monomer in an organic solvent with a silver salt, reducing the silver salt in situ to form silver nanoparticles of 35-60 nm, which are embedded within a PMMA matrix, using a free radical polymerization process with a low silver content and suitable organic free radical initiators.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If high silver content is used in antimicrobial polymeric materials, then bacterial growth inhibition effectiveness is improved, but material cost and complexity increase
Solution Approach 1:
The patent creates a composite nanocomposite material combining PMMA polymer matrix with silver nanoparticles. This composite structure allows the polymer to provide structural integrity and the silver nanoparticles to provide antimicrobial activity, achieving effective bacterial inhibition with low silver content (0.1-10 wt%). The composite approach resolves the contradiction by synergistically combining materials to achieve high effectiveness without requiring high silver content.
Solution Approach 2:
The patent changes the physical state and size parameter of silver from bulk or large particles to nanoparticles (1-100 nm diameter). This parameter change dramatically increases the surface area to volume ratio, enhancing antimicrobial effectiveness per unit mass of silver. The nanoscale dimension allows much lower silver content to achieve the same or better antimicrobial effect compared to traditional high silver content materials.
2Reliability
If complex synthesis processes are used to produce antimicrobial polymers, then material performance is improved, but manufacturing ease and cost-effectiveness deteriorate
Solution Approach 1:
The patent merges two separate processes into one: polymer synthesis and silver nanoparticle synthesis occur simultaneously in a single reaction step. The PMMA polymerization and silver nanoparticle formation are coupled, eliminating the need for separate synthesis, purification, and combination steps. This unified approach dramatically simplifies manufacturing while maintaining high antimicrobial performance.
Solution Approach 2:
The patent employs self-service mechanisms where the polymerization process itself generates the conditions needed for silver nanoparticle formation. The reducing agents and stabilizing agents are incorporated into the polymerization system, allowing the process to self-regulate nanoparticle synthesis without additional reagents or steps. The polymer matrix simultaneously serves as both structural material and nanoparticle stabilizer.
3Ease of manufacture
If silver content is reduced in antimicrobial materials, then cost and efficiency improve, but antibacterial effectiveness may worsen
Solution Approach 1:
The patent changes the size parameter of silver to nanoscale (1-100 nm), which fundamentally alters the relationship between silver content and effectiveness. The nanoscale dimension provides exponentially higher surface area to volume ratio, enabling much lower silver loading (0.1-10 wt%) to achieve effective antimicrobial activity. This parameter change resolves the contradiction by making low silver content equivalent to high silver content in traditional materials.
Solution Approach 2:
The patent creates a composite where silver nanoparticles are dispersed within the PMMA matrix at low concentrations. The composite structure ensures uniform distribution and prevents aggregation, maximizing the antimicrobial effectiveness of each silver nanoparticle. This composite approach allows cost-effective low silver content while maintaining high reliability through optimized material architecture.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The resulting PMMA/silver nanocomposite effectively inhibits bacterial growth with low silver content, demonstrating 70-95% inhibition of bacteria such as Bacillus, Escherichia, and Staphylococcus species, while maintaining mechanical and thermal stability, and can be applied to various surfaces and mediums with ease.
Implementation Method 1
polymerizing and/or reacting methyl methacrylate (MMA) monomer in at least one organic solvent, preferably free of water, and in the presence of at least one organic free radical initiator and at least one silver salt to form the PMMA by free radical polymerization
Implementation Method 2
reducing in-situ the silver salt to form the silver nanoparticles, wherein the silver nanoparticles have an average particle size of 35-60 nm
Implementation Method 3
wherein the PMMA forms a matrix that encloses the silver nanoparticles
Implementation Method 4
The resulting PMMA/silver nanocomposite effectively inhibits bacterial growth with low silver content, demonstrating 70-95% inhibition of bacteria such as Bacillus, Escherichia, and Staphylococcus species
Data Source
AI summary
A method of making an antimicrobial poly(methyl methacrylate) (PMMA)/silver nanocomposite comprising PMMA and silver nanoparticles. The method includes reacting at least one silver salt with a methyl methacrylate (MMA) monomer in at least one organic solvent free of water and in the presence of at least one organic free radical initiator to polymerize the MMA monomer to form the PMMA by free radical polymerization while reducing in-situ the silver salt to form the silver nanoparticles, wherein the silver nanoparticles have an average particle size of 35-60 nm, and wherein the PMMA forms a matrix that encloses the silver nanoparticles.